scholarly journals The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme—A Narrative Review

Molecules ◽  
2021 ◽  
Vol 26 (9) ◽  
pp. 2539
Author(s):  
Soo Liang Ooi ◽  
Sok Cheon Pak ◽  
Peter S. Micalos ◽  
Emily Schupfer ◽  
Catherine Lockley ◽  
...  
Keyword(s):  
Rice Bran ◽  
Complementary Therapy ◽  
Chronic Fatigue ◽  
Serum Glucose ◽  
Clinical Applications ◽  
Narrative Review ◽  
Diabetic Patients ◽  
Nonalcoholic Fatty Liver ◽  
Fatigue Syndrome ◽  
Health Promoting

Rice bran arabinoxylan compound (RBAC) is derived from defatted rice bran hydrolyzed with Lentinus edodes mycelial enzyme. It has been marketed as a functional food and a nutraceutical with health-promoting properties. Some research has demonstrated this rice bran derivative to be a potent immunomodulator, which also possesses anti-inflammatory, antioxidant, and anti-angiogenic properties. To date, research on RBAC has predominantly focused on its immunomodulatory action and application as a complementary therapy for cancer. Nonetheless, the clinical applications of RBAC can extend beyond cancer therapy. This article is a narrative review of the research on the potential benefits of RBAC for cancer and other health conditions based on the available literature. RBAC research has shown it to be useful as a complementary treatment for cancer and human immunodeficiency virus infection. It can positively modulate serum glucose, lipid and protein metabolism in diabetic patients. Additionally, RBAC has been shown to ameliorate irritable bowel syndrome and protect against liver injury caused by hepatitis or nonalcoholic fatty liver disease. It can potentially ease symptoms in chronic fatigue syndrome and prevent the common cold. RBAC is safe to consume and has no known side effects at the typical dosage of 2–3 g/day. Nevertheless, further research in both basic studies and human clinical trials are required to investigate the clinical applications, mechanisms, and effects of RBAC.

scholarly journals Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases

Nutrients ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1697
Author(s):  
Lara Testai ◽  
Alma Martelli ◽  
Lorenzo Flori ◽  
Alessandro Colletti ◽  
Arrigo F. G. Cicero
Keyword(s):  
Cardiovascular Diseases ◽  
Coenzyme Q10 ◽  
Inverse Correlation ◽  
Chronic Fatigue ◽  
Clinical Applications ◽  
Blood Levels ◽  
Muscle Disorders ◽  
Fatigue Syndrome ◽  
Antioxidant Agent

Coenzyme Q10 (CoQ10) is an essential cofactor in oxidative phosphorylation (OXPHOS), present in mitochondria and cell membranes in reduced and oxidized forms. Acting as an energy transfer molecule, it occurs in particularly high levels in the liver, heart, and kidneys. CoQ10 is also an anti-inflammatory and antioxidant agent able to prevent the damage induced by free radicals and the activation of inflammatory signaling pathways. In this context, several studies have shown the possible inverse correlation between the blood levels of CoQ10 and some disease conditions. Interestingly, beyond cardiovascular diseases, CoQ10 is involved also in neuronal and muscular degenerative diseases, in migraine and in cancer; therefore, the supplementation with CoQ10 could represent a viable option to prevent these and in some cases might be used as an adjuvant to conventional treatments. This review is aimed to summarize the clinical applications regarding the use of CoQ10 in migraine, neurodegenerative diseases (including Parkinson and Alzheimer diseases), cancer, or degenerative muscle disorders (such as multiple sclerosis and chronic fatigue syndrome), analyzing its effect on patients’ health and quality of life.

Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Emerging Osteopathic Approach: A Narrative Review

2019 ◽  
Vol 119 (7) ◽  
pp. 446
Author(s):  
Christopher Larrimore ◽  
Amanda Ramnot ◽  
Annmarie Jaghab ◽  
Sofia Sarduy ◽  
George Guerrero ◽  
...  
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Chronic Fatigue ◽  
Myalgic Encephalomyelitis ◽  
Narrative Review ◽  
Fatigue Syndrome

scholarly journals Moxibustion for Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Jianyu You ◽  
Jing Ye ◽  
Haiyan Li ◽  
Wenguo Ye ◽  
Ensi Hong
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Data Extraction ◽  
Meta Analysis ◽  
Complementary Therapy ◽  
Chronic Fatigue ◽  
Assessment Instrument ◽  
Favorable Effect ◽  
Control Group ◽  
Level Of Evidence ◽  
Fatigue Syndrome

Objective. This review aimed at systematically evaluating the efficacy and safety of moxibustion for chronic fatigue syndrome (CFS). Methods. Relevant trials were searched in seven digital databases up to January 2021. After literature screening, data extraction, and literature quality evaluation, the included studies were meta-analyzed using RevMan 5.4 software. The evidence level was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). Results. Fifteen studies involving 1030 CFS participants were included. Meta-analyses showed a favorable effect of moxibustion on the total effective rate compared with acupuncture (OR = 4.58, 95%CI = [2.85, 7.35], P < 0.00001 ) and drugs (OR = 6.36, 95%CI = [3.48, 11.59], P < 0.00001 ). Moxibustion also appeared to significantly reduce fatigue severity measured by fatigue scale-14 (FS-14) (WMD = −2.20, 95% CI = [−3.16, −1.24], P < 0.00001 ) and fatigue assessment instrument (FAI) (WMD = −16.36, 95% CI = [−26.58, −6.14], P = 0.002 ) compared with the control group. In addition, among the 15 included studies, only two studies reported adverse events related to moxibustion, and the symptoms were relatively mild. The quality of evidence based on the 15 included trials was assessed as moderate to very low. Conclusions. Based on limited evidence, moxibustion might be an effective and safe complementary therapy for CFS, which can be recommended to manage CFS. Because of the limited level of evidence in this review, further high-quality trials are still needed to confirm these findings.

Acupuncture in the Treatment of Post Viral Fatigue Syndrome – a Case Report

2005 ◽  
Vol 23 (3) ◽  
pp. 141-145 ◽  
Author(s):  
Tim Mears
Keyword(s):  
Case Report ◽  
Chronic Fatigue Syndrome ◽  
Return To Work ◽  
Acupuncture Treatment ◽  
Complementary Therapy ◽  
Chronic Fatigue ◽  
Fatigue Syndrome

This case report concerns the treatment of post viral fatigue (chronic fatigue syndrome) with electroacupuncture. This condition is particularly difficult to treat whether using conventional or complementary therapy. Whilst the treatment did not cure the patient, it appears to have facilitated her return to work and markedly improved her symptoms. There are few publications on acupuncture treatment of this condition and the approach used here has not been reported previously.

The role of sleep in chronic fatigue syndrome: a narrative review

2014 ◽  
Vol 2 (3) ◽  
pp. 163-184 ◽  
Author(s):  
Zoe M. Gotts ◽  
Jason G. Ellis ◽  
Julia L. Newton ◽  
Vincent Deary
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Chronic Fatigue ◽  
Narrative Review ◽  
Fatigue Syndrome

Qi Therapy (External Qigong) for Chronic Fatigue Syndrome: Case Studies

2005 ◽  
Vol 33 (01) ◽  
pp. 139-141 ◽  
Author(s):  
Yong-Il Shin ◽  
Myeong Soo Lee
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Case Studies ◽  
Negative Symptoms ◽  
Complementary Therapy ◽  
Chronic Fatigue ◽  
Conclusive Evidence ◽  
Chronic Fatigue Syndrome Case ◽  
Fatigue Syndrome

The aim of this study was to examine the effects of Qi therapy (QT) on the symptoms of chronic fatigue syndrome (CFS), including fatigue and complications. QT affected the experience of mental and emotional relaxation in the subjects of these case studies, who also gained strength to overcome their pain and fatigue. Although the results of these two case studies may not constitute conclusive evidence, they provide a foundation for the exploration of QT as a complementary therapy in the reduction of negative symptoms of chronic fatigue syndrome.

scholarly journals Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent

2016 ◽  
Vol 23 (1) ◽  
pp. 127-138 ◽  
Author(s):  
Keith J Geraghty ◽  
Charlotte Blease
Keyword(s):  
Informed Consent ◽  
Chronic Fatigue Syndrome ◽  
Cognitive Behavioural Therapy ◽  
Chronic Fatigue ◽  
Behavioural Therapy ◽  
Narrative Review ◽  
Fatigue Syndrome ◽  
Cognitive Behavioural ◽  
Term Benefit

Cognitive behavioural therapy is increasingly promoted as a treatment for chronic fatigue syndrome. There is limited research on informed consent using cognitive behavioural therapy in chronic fatigue syndrome. We undertook a narrative review to explore efficacy and to identify the salient information that should be disclosed to patients. We found a complex theoretical model underlying the rationale for psychotherapy in chronic fatigue syndrome. Cognitive behavioural therapy may bring about changes in self-reported fatigue for some patients in the short term, however there is a lack of evidence for long-term benefit or for improving physical function and cognitive behavioural therapy may cause distress if inappropriately prescribed. Therapist effects and placebo effects are important outcome factors.

Sign in / Sign up

Export Citation Format

Share Document